Canada· CA-DIN-02453452

APO-OLMESARTAN

A olmesartan medoxomil product containing olmesartan medoxomil, registered in Canada by APOTEX INC. The same ATC class is registered in 15 of our 19 countries.

ATC C09CA08

Checked against Health Canada Drug Product Database (Canada) on October 1, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about olmesartan medoxomilAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Olmesartan medoxomil is registered in 15 of 19 countries.

Countries holding a registration under ATC C09CA08 (olmesartan medoxomil), each read from that country’s own register.

This record: Canada, from Health Canada Drug Product Database (Canada)
10 of them publish a price we can compare per daily dose

Search olmesartan medoxomil products by name

Olmesartan medoxomil · ATC C09CA08

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Spainprice
Switzerlandprice
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of olmesartan medoxomil costs, country by country.

Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.33 in Italy to $0.86 in Switzerland — a ×2.6 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Olmesartan medoxomil · price per daily dose (20 mg)

USD · FX 28 Sept 2026

CH Switzerland$0.86
ES Spain$0.41
IT Italy$0.33

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Health Canada Drug Product Database (Canada)

Active substance: OLMESARTAN MEDOXOMIL
Manufacturer: APOTEX INC
Country: Canada (CA)
ATC code: C09CA08
ATC class: Olmesartan medoxomil
Defined daily dose: 20 mg, O
Reimbursed: Not published by this register
Source register: Health Canada Drug Product Database (Canada)
Last checked: October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

216 interactions on record for olmesartan medoxomil.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check olmesartan medoxomil against other medicines How interaction checks work

Olmesartan medoxomil · interactions on record

216 records

7 severe
128 moderate

Most severe, free to view

Potassium chlorideA12BA01severe
Potassium citrateA12BA02severe
Potassium gluconateA12BA05severe
Potassium chlorideB05XA01severe

81 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Olmesartan medoxomil in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All olmesartan medoxomil products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

Austria · Mencord, Olmeblo
Belgium · Belsar, Olmesartan Ab
Bulgaria · Tansidor, Амлосарт
Cyprus · Olmesartan Medoxomil Jubilant, Olmesartan Tad
Czechia · Sarten, Zeota
Germany · Olmecor, Olmes
Denmark · Olmesartan Medoxomil Krka
Estonia · Mesar, Olimestra
Spain · Atolme, Ixia
Finland · Olmesartan Medoxomil Krka, Olmesartan Medoxomil Stada
France · Alteis, Olmetec
United Kingdom (Northern Ireland) · Olmesartan, Olmesartan Glenmark Pharmaceuticals Europe
Greece · Ipertas, Olmesartan Sandoz
Croatia · Olimestra, Olmesartan Genericon
Hungary · Laresin
Ireland · Olmesartan Krka, Olmesartan Medoxomil Accord Healthcare
Italy · Cardol, Idalman
Lithuania · Mesar, Olimestra
Luxembourg · Belsar, Olmesartan Eg
Latvia · Mesar, Olimestra
Malta · Olmesartan Aurobindo Pharma (Malta), Olmesartan Vocate
Netherlands · Olmesartan Medoxomil Accord, Olmesartan Medoxomil Aurobindo
Norway · Olmesartan Medoxomil Accord, Olmesartan Medoxomil Krka
Poland · Olimestra, Olmesartan Lek-Am
Portugal · Atolme, Condronac
Romania · Olmetec, Santini
Slovenia · Olimestra, Tensiol
Slovakia · Tenzar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/85dc0a0b-93fc-400a-83ec-c0c9d88ea40b
GET /v1/drugs/85dc0a0b-93fc-400a-83ec-c0c9d88ea40b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02453452",
  "form": "TABLET",
  "class": "Human",
  "routes": [
    "ORAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "C09CA08",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "94000",
  "strengths": [
    "20 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "OLMESARTAN MEDOXOMIL"
  ],
  "product_categorization": null
}

API reference MCP server Plans

See everything about olmesartan medoxomil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console